Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Premier Research Consulting, LLC

  • FDA Approval
  • April 21, 2025, 14:28 UTC
  • 21

FDA approve ARIPIPRAZOLE

Comment Full text

NOVITIUM PHARMA

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 19

FDA approve MESALAMINE

Comment Full text

AMNEAL PHARMS

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 11

FDA approve MONTELUKAST SODIUM

Comment Full text

BAUSCH

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 12

FDA approve DILTIAZEM HYDROCHLORIDE

Comment Full text

HETERO LABS LTD V

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 13

FDA approve ABACAVIR SULFATE; LAMIVUDINE

Comment Full text

ALEMBIC

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 17

FDA approve CARBAMAZEPINE

Comment Full text

HIKMA

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 19

FDA approve DEXMEDETOMIDINE HYDROCHLORIDE

Comment Full text

BAUSCH

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 13

FDA approve DILTIAZEM HYDROCHLORIDE

Comment Full text

LEADING

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 19

FDA approve FROVATRIPTAN SUCCINATE

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 16

FDA approve ESOMEPRAZOLE MAGNESIUM

Comment Full text
  • Previous
  • 53
  • 54
  • 55
  • 56
  • 57
  • Next

Search

News categories

  • Technical Exchange News(9492)
  • Event(407)
  • SEC News(155849)
  • FDA Approval(8880)
  • Company Report(721)
  • Business News(105726)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin